ClinicalTrials.govpublic full text
Open Label Extension of Prior TERMS Study to Treat Relapsing Forms of Multiple Sclerosis
multiple sclerosis, relapsing-remitting, clinically isolated syndrome, tovaxin, autologous, t-cell vaccine (tcv), interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 915608
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.